Keywords: halcygen, target, 1b, drugs, sector, australian, drug
HalcyGen to target $1B drugs sector
Article | 11 June 2007
Australian drug developer HalcyGen Pharmaceuticals says that it will raise A$12.5 million ($10.2 million) in a fully-underwritten initial public offering to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
